Redness is an excellent example of why aesthetic-device shopping gets ahead of diagnosis.
A clinic may offer VBeam, IPL, BBL, Excel V or another vascular/light platform and describe all of them as ways to “take down redness.” The color may look similar in the mirror. The underlying pattern, target vessels, skin tone and device physics can be quite different.
For persistent facial erythema and visible vessels—especially in rosacea—the two names consumers most often compare are pulsed-dye laser and IPL. Both can be useful. They are not the same treatment.
VBeam is a pulsed-dye laser, not a generic redness machine
VBeam is a well-known brand of pulsed-dye laser, commonly operating around 595 nm. PDL is designed to target hemoglobin in blood vessels, making vascular lesions and persistent erythema logical indications.
Because it is a laser, the device delivers a specific wavelength rather than the broad spectrum used by IPL. Pulse duration, fluence, spot size and cooling still influence the treatment. The brand name does not eliminate parameter judgment.
IPL uses a broad spectrum and filters the light
IPL is not a laser. It uses broad-spectrum light filtered into ranges selected for vascular or pigment targets. That versatility is one reason IPL/BBL is popular for patients who have a mixture of redness and sun-related pigment.
The broader optical range can be useful. It also means skin pigment and filter selection matter. A “photofacial” is not automatically the same plan for every person with a red cheek.
What comparative evidence says about rosacea
A 2024 systematic review and meta-analysis directly comparing IPL and PDL for rosacea included four studies and 141 participants. Both modalities appeared effective. The analysis did not find a statistically significant difference in achieving greater than 50% clearance or change in erythema index. IPL showed an advantage for greater-than-75% clearance in the pooled analysis, while PDL had lower reported pain scores.
The important limitation is the size of the evidence base. Four comparative studies are not enough to declare a universal winner across rosacea phenotypes, devices, settings and skin tones.
A more recent systematic review and network meta-analysis of energy-based devices for rosacea likewise supports the broader conclusion: several laser/light modalities can improve selected rosacea signs, and treatment choice remains indication- and patient-dependent.
Rosacea is more than vessels
Rosacea can involve persistent color, flushing, visible vessels, acne-like inflammatory lesions, burning, stinging and eye symptoms. A vascular device addresses selected vascular manifestations; it does not automatically treat every feature of rosacea.
The American Academy of Dermatology notes that laser therapy can reduce persistent color changes, while medications may be used for acne-like breakouts and other manifestations.
If a clinic calls the entire condition a “redness problem,” ask what part of the rosacea it expects the device to change.
Visible vessels and diffuse redness are related, not identical
A discrete telangiectatic vessel may be approached differently from broad background erythema. Vessel diameter, depth and color can affect wavelength and parameter choice.
That is one reason “VBeam or IPL?” is not answerable from a selfie. A clinician needs to identify whether the dominant target is diffuse erythema, individual vessels, mixed photodamage or another source of redness.
Skin tone changes the optical margin
Both PDL and IPL involve light interacting with skin that contains melanin as well as hemoglobin. Darker or recently tanned epidermis can change energy absorption and pigment risk.
Darker skin can absolutely be treated with vascular and light-based technology, but the provider should have relevant experience with the exact platform and skin tone. Ask about test spots, conservative settings, cooling and post-inflammatory hyperpigmentation risk.
Do not accept “safe for all skin types” as the entire answer.
Purpura is part of the PDL conversation
Some pulsed-dye laser settings can produce purpura—temporary purple bruising-like discoloration caused by vascular injury. Other settings may be designed to minimize purpura.
Ask whether the intended treatment is purpuric or non-purpuric, what that means for the expected result and how long visible discoloration may last. “No downtime” and a purple cheek are difficult phrases to reconcile after the appointment.
IPL may make more sense when pigment and vessels share the face
For selected patients with both vascular redness and sun-related lentigines, IPL’s broad-spectrum approach may allow a provider to address more than one optical target in a treatment plan.
That does not mean IPL is automatically preferable. Melasma, PIH risk, darker skin, recent tanning and the exact vascular pattern can change the equation.
If pigment is part of the reason for choosing IPL, read Sun Spots, PIH, or Melasma? Pigment Is Not One Laser Problem before treating “brown and red” as one category.
The consultation questions
- Is the redness rosacea, discrete vessels, post-inflammatory redness or another diagnosis?
- Am I treating diffuse erythema, visible vessels or both?
- Why PDL rather than IPL—or IPL rather than PDL?
- What exact wavelength/filter and settings strategy are being used?
- Will the PDL settings produce purpura?
- How does my skin tone and recent sun exposure change the plan?
- How many sessions are realistic?
- What rosacea symptoms will this not treat?
- What medication or skincare plan remains necessary?
The Verdict
PDL and IPL are both legitimate tools for selected redness and rosacea. The evidence does not support turning the comparison into a beauty-device championship.
VBeam’s pulsed-dye laser is a focused vascular tool. IPL is a broader light platform that can address selected vascular and pigment targets. The better choice depends on what is actually red, what else is happening in the skin, how much pigment is present and how the provider plans to use the device.
Same color problem. Different light. Diagnosis still gets first billing.
Evidence check: Moderate
Evidence level: moderate for PDL and IPL in selected rosacea-related erythema and vascular concerns; direct head-to-head evidence remains limited.
Sources reviewed August 8, 2026:
This article is general education. Persistent or unexplained facial redness can have causes other than rosacea and should be appropriately assessed before cosmetic treatment.